A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy

Bezemer, Danielaa; de Wolf, Franka,b; Boerlijst, Maarten Cc; van Sighem, Arda; Hollingsworth, T Deirdreb; Prins, Mariad,e; Geskus, Ronald Bd,f; Gras, Luuka; Coutinho, Roel Ag,h; Fraser, Christopheb

doi: 10.1097/QAD.0b013e3282fd167c
Epidemiology and Social

Objective: Reducing viral load, highly active antiretroviral therapy has the potential to limit onwards transmission of HIV-1 and thus help contain epidemic spread. However, increases in risk behaviour and resurgent epidemics have been widely reported post-highly active antiretroviral therapy. The aim of this study was to quantify the impact that highly active antiretroviral therapy had on the epidemic.

Design: We focus on the HIV-1 epidemic among men who have sex with men in the Netherlands, which has been well documented over the past 20 years within several long-standing national surveillance programs.

Methods: We used a mathematical model including highly active antiretroviral therapy use and estimated the changes in risk behaviour and diagnosis rate needed to explain annual data on HIV and AIDS diagnoses.

Results: We show that the reproduction number R(t), a measure of the state of the epidemic, declined early on from initial values above two and was maintained below one from 1985 to 2000. Since 1996, when highly active antiretroviral therapy became widely used, the risk behaviour rate has increased 66%, resulting in an increase of R(t) to 1.04 in the latest period 2000–2004 (95% confidence interval 0.98–1.09) near or just above the threshold for a self-sustaining epidemic. Hypothetical scenario analysis shows that the epidemiological benefits of highly active antiretroviral therapy and earlier diagnosis on incidence have been entirely offset by increases in the risk behaviour rate.

Conclusion: We provide the first detailed quantitative analysis of the HIV epidemic in a well defined population and find a resurgent epidemic in the era of highly active antiretroviral therapy, most likely predominantly caused by increasing sexual risk behaviour.

Author Information

From the aHIV Monitoring Foundation, Amsterdam, The Netherlands

bDepartment of Infectious Disease Epidemiology, Imperial College London, UK

cInstitute for Biodiversity and Ecosystem Dynamics, University of Amsterdam, The Netherlands

dHealth Service Amsterdam, The Netherlands

eCenter for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, The Netherlands

fDepartment of Clinical Epidemiology Biostatistics and Bioinformatics, Academic Medical Center, The Netherlands

gDepartment of Human Retrovirology, Academic Medical Center, University of Amsterdam, The Netherlands

hCenter for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, The Netherlands.

Received 9 May, 2007

Revised 7 February, 2008

Accepted 15 February, 2008

Correspondence to Christophe Fraser, Department of Infectious Disease Epidemiology, Faculty of Medicine at St Mary's Campus, Imperial College London, London, W2 1PG. UK. E-mail: c.fraser@imperial.ac.uk

© 2008 Lippincott Williams & Wilkins, Inc.